StockData
Alto Neuroscience, Inc. logo

Alto Neuroscience, Inc. (ANRO) stock

ANRONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$24.91−2.21 (-8.15%)

Close on Nov 17, 2026Market cap $977.52MP/E –Yield –

Alto Neuroscience market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Alto Neuroscience's market cap was $1.09B on Nov 11, 2026, against $376.28M a year earlier. Over the last 3 years it ranged from $58.29M to $1.24B, with a median of $308.31M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.09B+126.1%
2025Dec 31, 2025$483.60M+323.9%
2024Dec 31, 2024$114.08M–

More Alto Neuroscience figures

See a number that looks wrong?